Article thumbnail

Target drug delivery system as a new scarring modulation after glaucoma filtration surgery

By Tingting Shao, Xiaoning Li and Jian Ge
Topics: Hypothesis
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2002). Allemann E: State of the art in the delivery of photosensitizers for photodynamic therapy. Journal of photochemistry and photobiology
  2. (2007). Aslanides IM: Uses and complications of mitomycin C in ophthalmology. Expert opinion on drug safety
  3. (2006). Ayyala RS: Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels.
  4. (2005). Cell targeting by a generic receptor-targeted polymer nanocontainer platform. J Control Release
  5. (2001). Cordeiro MF: Modulation of wound healing after glaucoma surgery. Current opinion in ophthalmology
  6. (2006). Dosage and kinetics of MMC release of a collagen implant used as a delivery device in glaucoma surgery in the rabbit eye. Journal francais d’ophtalmologie
  7. (2009). Dynamic alteration of lowdensity lipoprotein receptor after exposure to transforming growth Shao et al.
  8. (2009). Eliott D: Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Investigative ophthalmology & visual science
  9. (2007). Forte TM: Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme. International journal of pharmaceutics
  10. (2009). Functional proteomics of failed filtering blebs. Molecular vision
  11. (2005). High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. Journal of biomedical optics
  12. (2008). HS: Tissue bioengineering for surgical bleb defects: an animal study. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
  13. (2008). Khaw PT: Modulation of wound healing during and after glaucoma surgery. Progress in brain research
  14. (2005). Khaw PT: Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Investigative ophthalmology & visual science
  15. (2000). Khaw PT: The role of the immune system in conjunctival wound healing after glaucoma surgery. Survey of ophthalmology
  16. (2003). Krieglstein GK: Photodynamic modulation of wound healing in glaucoma filtration surgery. The British journal of ophthalmology
  17. (2006). Leibovitch I: Mitomycin: clinical applications in ophthalmic practice. Drugs
  18. (2006). Long-term followup of initial trabeculectomy with mitomycin C for primary open-angle glaucoma in Japanese patients.
  19. (2003). MK: The inhibition effect of photodynamic on human Tenon capsule fibroblast cells. Chinese journal of ophthalmology
  20. (2004). MR and fluorescent imaging of low-density lipoprotein receptors. Academic radiology
  21. (2004). N-succinyl-chitosan as a drug carrier: waterinsoluble and water-soluble conjugates. Biomaterials
  22. (2007). Nanoparticle-mediated drug delivery and gene therapy. Biotechnology progress
  23. (2009). Ravinet E: Effect of different application depths of mitomycin-C in deep sclerectomy with collagen implant: a randomized controlled trial. Clinical & experimental ophthalmology
  24. (2004). Shaarawy T: In vitro release of mitomycin C from collagen implants. Current eye research
  25. (2009). Solid hyaluronic acid film and the prevention of postoperative fibrous scar formation in experimental animal eyes. Archives of ophthalmology
  26. (1992). Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin. Chemical & pharmaceutical bulletin
  27. (2010). Zheng Qiongjuan, Li Xiaoning, Quan Daping, Ge Jian: Synthesisi and controlled release of a chitosan-based polymeric prodrug of mitomycin C [abstract]. Symposium on innovative polymers for controlled delivery